Company Filing History:
1 out of 138 
1 out of 26 
1 out of 523 
Years Active: 2003-2008
Title: Franzanne Vreeland: Innovator in Cancer Treatment
Introduction
Franzanne Vreeland is a notable inventor based in Martinsville, NJ (US). He has made significant contributions to the field of cancer treatment, holding a total of 3 patents. His work focuses on innovative therapies aimed at improving patient outcomes in oncology.
Latest Patents
Vreeland's latest patents include an antitumor therapy comprising distamycin derivatives. This invention relates to an administration schedule that involves the intravenous administration of an α-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. This method allows for the treatment of various tumors in mammals. Another significant patent is a method for predicting the sensitivity to chemotherapy. This invention pertains to predicting a patient's sensitivity to chemotherapy by measuring glutathione (GSH) blood levels in patients undergoing chemotherapeutic treatment.
Career Highlights
Throughout his career, Vreeland has worked with various organizations, including Nerviano Medical Sciences S.r.l. His innovative approaches have contributed to advancements in cancer therapies and patient care.
Collaborations
Vreeland has collaborated with notable colleagues such as Camilla Fowst and Maria Cristina Rosa Geroni. Their combined expertise has furthered the development of effective cancer treatment methodologies.
Conclusion
Franzanne Vreeland's contributions to cancer treatment through his patents and collaborations highlight his commitment to improving patient care. His innovative work continues to influence the field of oncology.